Literature DB >> 3122725

The interaction of streptokinase.plasminogen activator complex, tissue-type plasminogen activator, urokinase and their acylated derivatives with fibrin and cyanogen bromide digest of fibrinogen. Relationship to fibrinolytic potency in vitro.

R Cassels1, R Fears, R A Smith.   

Abstract

The effects of purified soluble fibrin and of fibrinogen fragments (fibrin mimic) on the activation of Lys-plasminogen (i.e. plasminogen residues 77-790) to plasmin by streptokinase.plasminogen activator complex and by tissue-type plasminogen activator were studied. Dissociation constants of both activators were estimated to lie in the range 90-160 nM (fibrin) and 16-60 nM (CNBr-cleavage fragments of fibrinogen). The kinetic mechanism for both types of activator comprised non-essential enzyme activation via a Rapid Equilibrium Ordered Bireactant sequence. In order to relate the fibrin affinity of plasminogen activators to their fibrinolytic potency, the rate of lysis of supported human plasma clots formed in the presence of unmodified or active-centre-acylated precursors of plasminogen activators was studied as a function of the concentration of enzyme derivative. The concentrations of unmodified enzyme giving 50% lysis/h in this assay were 0.9, 2.0 and 11.0 nM for tissue-type plasminogen activator, streptokinase.plasmin(ogen) and urokinase respectively. However, the potencies of active-centre-acylated derivatives of these enzymes suggested that acylated-tissue plasminogen activator and streptokinase.plasminogen complexes of comparable hydrolytic stability were of comparable potency. Both types of acyl-enzyme were significantly more potent than acyl-urokinases.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3122725      PMCID: PMC1148422          DOI: 10.1042/bj2470395

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  30 in total

1.  Induction of a sustained fibrinolytic response by BRL 26921 in vitro.

Authors:  R Fears; J Green; R A Smith; P Walker
Journal:  Thromb Res       Date:  1985-05-01       Impact factor: 3.944

2.  Coronary thrombolysis with intravenous anisoylated plasminogen-streptokinase complex BRL 26921.

Authors:  M Been; D P de Bono; A L Muir; F E Boulton; W S Hillis; R Hornung
Journal:  Br Heart J       Date:  1985-03

3.  Kinetics of the activation of plasminogen by natural and recombinant tissue-type plasminogen activator.

Authors:  C Zamarron; H R Lijnen; D Collen
Journal:  J Biol Chem       Date:  1984-02-25       Impact factor: 5.157

4.  Common evolutionary origin of the fibrin-binding structures of fibronectin and tissue-type plasminogen activator.

Authors:  L Bányai; A Váradi; L Patthy
Journal:  FEBS Lett       Date:  1983-10-31       Impact factor: 4.124

5.  Kinetic studies on the interaction of streptokinase and other plasminogen activators with plasminogen and fibrin.

Authors:  R Fears; M J Hibbs; R A Smith
Journal:  Biochem J       Date:  1985-07-15       Impact factor: 3.857

6.  A comparison of three different prophylactic parenteral antibiotic regimens in colorectal surgery: a prospective study.

Authors:  F Lozano; A Gomez Alonso; A Almazan; J Garcia Garcia; F Cuadrado; M Rodriguez Morgan
Journal:  Int Surg       Date:  1985 Jul-Sep

7.  Effects of human fibrinogen and its cleavage products on activation of human plasminogen by streptokinase.

Authors:  B A Chibber; J P Morris; F J Castellino
Journal:  Biochemistry       Date:  1985-07-02       Impact factor: 3.162

8.  Influence of cyanogen-bromide-digested fibrinogen on the kinetics of plasminogen activation by urokinase.

Authors:  H R Lijnen; B Van Hoef; D Collen
Journal:  Eur J Biochem       Date:  1984-11-02

9.  Quantitative characterization of the binding of plasminogen to intact fibrin clots, lysine-sepharose, and fibrin cleaved by plasmin.

Authors:  R A Bok; W F Mangel
Journal:  Biochemistry       Date:  1985-06-18       Impact factor: 3.162

10.  Increased yield of human tissue-type plasminogen activator obtained by means of recombinant DNA technology.

Authors:  M J Browne; I Dodd; J E Carey; C G Chapman; J H Robinson
Journal:  Thromb Haemost       Date:  1985-08-30       Impact factor: 5.249

View more
  3 in total

Review 1.  Binding of plasminogen activators to fibrin: characterization and pharmacological consequences.

Authors:  R Fears
Journal:  Biochem J       Date:  1989-07-15       Impact factor: 3.857

2.  Kinetic studies on novel plasminogen activators. Demonstration of fibrin enhancement for hybrid enzymes comprising the A-chain of plasmin (Lys-78) and B-chain of tissue-type plasminogen activator (Ile-276) or urokinase (Ile-159).

Authors:  R Fears; I Dodd; H Ferres; J H Robinson
Journal:  Biochem J       Date:  1990-03-15       Impact factor: 3.857

3.  Soluble fibrin preparations inhibit the reaction of plasmin with alpha 2-macroglobulin. Comparison with alpha 2-antiplasmin and leupeptin.

Authors:  P K Anonick; S L Gonias
Journal:  Biochem J       Date:  1991-04-01       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.